What's new? Log in Free sign up

Filing search / Nkarta, Inc. / "Pandemic"

Search information

Nkarta, Inc.

Companies

"Pandemic"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

56 results

Newest first Best match first

NKTX Nkarta, Inc.

Quarterly report

activities. If these health authorities need to prioritize efforts related to a pandemic, epidemic, or outbreak of infectious disease, including future … subject us to enforcement action. For example, government measures taken in response to the COVID-19 pandemic had a significant impact on our CROs

13 Aug 24

4:08pm

NKTX Nkarta, Inc.

Quarterly report

trials, product development, and manufacturing activities. If these health authorities need to prioritize efforts related to a pandemic, epidemic … to enforcement action. For example, government measures taken in response to the COVID-19 pandemic had a significant impact on our CROs, and similar

9 May 24

4:14pm

NKTX Nkarta, Inc.

Prospectus supplement for primary offering

of health epidemics, including the COVID-19 pandemic, in regions where we or third parties on which we rely have business operations; our dependence

NKTX Nkarta, Inc.

activities. If these health authorities need to prioritize efforts related to a pandemic, epidemic, or outbreak of infectious disease, including future … in response to the COVID-19 pandemic had a significant impact on our CROs, and similar measures in response to future pandemics, epidemics, or outbreaks

21 Mar 24

4:23pm

NKTX Nkarta, Inc.

Quarterly report

pandemic, in regions where we or third parties on which we rely have business operations. We have entered into a research collaboration with CRISPR … on March 16, 2023. COVID-19 Pandemic The COVID-19 pandemic has caused disruptions in the global economy and has affected and may affect the Company’s

9 Nov 23

4:19pm

4v6nvwq3zotyocuda3w

Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights

Quarterly report

10 Aug 23

7:15am

Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights

wmb3 s65pdb11uz

Nkarta Appoints Alyssa Levin Chief Financial and Business Officer

Quarterly report

11 May 23

4:19pm

Nkarta Reports First Quarter 2023 Financial Results and Corporate Highlights

Shelf registration (amended)

Nkarta Announces Departure of Chief Financial & Business Officer

Quarterly report

9 Nov 22

4:10pm

nq815qn6 5clvs0z

Nkarta Reports Third Quarter 2022 Financial Results and Corporate Highlights

Quarterly report

11 Aug 22

4:20pm

Nkarta Reports Second Quarter 2022 Financial Results and Corporate Highlights

6u0f 73hv4q4djop7

Nkarta Appoints David R. Shook, MD, as Vice President, Clinical Development

Quarterly report

12 May 22

4:25pm

Nkarta Reports First Quarter 2022 Financial Results and Corporate Highlights

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.